Yuyu Pharma, Inc. 000220

Robert Wonsang Yu, CEO of Yuyu Pharma (KRX: 000220), attended Amazon Accelerate 2026 in Seattle from September 22 to 24 to explore how Amazon's newest AI, consumer data, advertising and logistics tools can help grow Ari's Purrfect, Yuyu Pharma's U.S. feline-health brand.

Yuyu Teijin Medicare, a home healthcare joint venture between Yuyu Pharma of Korea and Teijin Pharma of Japan, has completed a pilot delivery of medical supplies by drone to a ventilator patient living on a remote Korean island.

Yuyu Pharma (KRX: 000220) has completed a major expansion of solar power at its manufacturing facility in Korea, bringing the site's total on-site solar capacity to approximately 1 megawatt (MW). The new 869-kilowatt (kW) solar system builds on earlier installations of 30 kW in 2020 and 96.6 kW in 2021. Together, the solar systems are expected to provide more than 30% of the electricity used at the manufacturing facility.

Robert Wonsang Yu, CEO of Yuyu Pharma, has launched "Robert's YUniverse", a new podcast series featuring conversations with guests from across culture, business and animal health.

Ari's Purrfect Omega+Multivitamin Lickable Supplement expands the Feline First product line as Yuyu Pharma's U.S. pet subsidiary approaches a full year of growth at Magnify on UCLA campus.

Mervyn's Petcare, the U.S. subsidiary of Korea-based Yuyu Pharmaceutical (KRX: 000220), has launched its first cat dental care nutritional supplement product, "Ari's Purrfect Dental Bites," on Amazon. This launch marks the company's initial foray into the U.S. pet health market and a significant milestone in its global expansion strategy.

Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector.